中国医师杂志
中國醫師雜誌
중국의사잡지
JOURNAL OF CHINESE PHYSICIAN
2014年
4期
468-470
,共3页
曾学辉%李忠新%张春雷%宋林立
曾學輝%李忠新%張春雷%宋林立
증학휘%리충신%장춘뢰%송림립
糖尿病肾病/代谢%脂肪酸结合蛋白质类%肌酸酐/代谢%血红蛋白A,糖基化/代谢%血红蛋白类/代谢%白蛋白类/代谢
糖尿病腎病/代謝%脂肪痠結閤蛋白質類%肌痠酐/代謝%血紅蛋白A,糖基化/代謝%血紅蛋白類/代謝%白蛋白類/代謝
당뇨병신병/대사%지방산결합단백질류%기산항/대사%혈홍단백A,당기화/대사%혈홍단백류/대사%백단백류/대사
Diabetic nephropathies/metabolism%Fatty acid-binding proteins%Creatinine/metabolism%Hemoglobin A,glyco-sylated/metabolism%Hemoglobins/metabolism%Albumins/metabolism
目的:探讨尿肝型脂肪酸结合蛋白( L-FABP)与糖尿病肾病进展的关系。方法选择1型和2型糖尿病患者132例,依据尿蛋白/肌酐比(ACR)和血清肌酐水平分为正常蛋白尿组(45例),微量蛋白尿组(36例),临床白蛋白尿组(30例),肾功能衰竭组(21例),以65例健康体检者为对照组,酶联免疫吸附法( ELISA )测定尿L-FABP含量,同时检测血肌酐(Scr)、尿肌酐、肝功能、血红蛋白、糖化血红蛋白(HbA1c)、白蛋白(Alb)、24 h尿蛋白量、尿白蛋白等指标。结果随着糖尿病肾病的进展,尿L-FABP水平逐渐增高(各组间比较P <0.01),亚组分析显示正常白蛋白组尿L-FABP水平高于健康组( P<0.05),微量白蛋白组尿L-FABP水平高于正常白蛋白组( P <0.01),临床白蛋白组尿L-FABP水平高于微量白蛋白组( P<0.01),肾功能衰竭组尿L-FABP水平高于临床白蛋白组( P <0.01);尿L-FABP水平与估计肾小球滤过率( eGFR )呈负相关( r =-0.812, P <0.01),尿L-FABP水平与Scr呈正相关( r =0.901, P <0.01),与HbA1c无关( P >0.05)。结论尿L-FABP水平不但可以更早预测糖尿病肾病的发生,还可以监测糖尿病肾病的进展。
目的:探討尿肝型脂肪痠結閤蛋白( L-FABP)與糖尿病腎病進展的關繫。方法選擇1型和2型糖尿病患者132例,依據尿蛋白/肌酐比(ACR)和血清肌酐水平分為正常蛋白尿組(45例),微量蛋白尿組(36例),臨床白蛋白尿組(30例),腎功能衰竭組(21例),以65例健康體檢者為對照組,酶聯免疫吸附法( ELISA )測定尿L-FABP含量,同時檢測血肌酐(Scr)、尿肌酐、肝功能、血紅蛋白、糖化血紅蛋白(HbA1c)、白蛋白(Alb)、24 h尿蛋白量、尿白蛋白等指標。結果隨著糖尿病腎病的進展,尿L-FABP水平逐漸增高(各組間比較P <0.01),亞組分析顯示正常白蛋白組尿L-FABP水平高于健康組( P<0.05),微量白蛋白組尿L-FABP水平高于正常白蛋白組( P <0.01),臨床白蛋白組尿L-FABP水平高于微量白蛋白組( P<0.01),腎功能衰竭組尿L-FABP水平高于臨床白蛋白組( P <0.01);尿L-FABP水平與估計腎小毬濾過率( eGFR )呈負相關( r =-0.812, P <0.01),尿L-FABP水平與Scr呈正相關( r =0.901, P <0.01),與HbA1c無關( P >0.05)。結論尿L-FABP水平不但可以更早預測糖尿病腎病的髮生,還可以鑑測糖尿病腎病的進展。
목적:탐토뇨간형지방산결합단백( L-FABP)여당뇨병신병진전적관계。방법선택1형화2형당뇨병환자132례,의거뇨단백/기항비(ACR)화혈청기항수평분위정상단백뇨조(45례),미량단백뇨조(36례),림상백단백뇨조(30례),신공능쇠갈조(21례),이65례건강체검자위대조조,매련면역흡부법( ELISA )측정뇨L-FABP함량,동시검측혈기항(Scr)、뇨기항、간공능、혈홍단백、당화혈홍단백(HbA1c)、백단백(Alb)、24 h뇨단백량、뇨백단백등지표。결과수착당뇨병신병적진전,뇨L-FABP수평축점증고(각조간비교P <0.01),아조분석현시정상백단백조뇨L-FABP수평고우건강조( P<0.05),미량백단백조뇨L-FABP수평고우정상백단백조( P <0.01),림상백단백조뇨L-FABP수평고우미량백단백조( P<0.01),신공능쇠갈조뇨L-FABP수평고우림상백단백조( P <0.01);뇨L-FABP수평여고계신소구려과솔( eGFR )정부상관( r =-0.812, P <0.01),뇨L-FABP수평여Scr정정상관( r =0.901, P <0.01),여HbA1c무관( P >0.05)。결론뇨L-FABP수평불단가이경조예측당뇨병신병적발생,환가이감측당뇨병신병적진전。
Objective To investigate the relationship of urinary liver-type fatty-acid binding protein and progression of ne-phropathy in diabetic patients .Methods A total of 132 cases of type 1 and type 2 diabetic patients were recruited in this study , and were divided into four groups based on the urine albumin /creatinine and serum creatinine levels , including normal albuminuria group ( n =45), microalbuminuria group ( n =36), clinical albuminuria group ( n =30), and renal failure group ( n =21), Additional 65 healthy subjects were recruited as control group .The levels of urinary liver-type fatty-acid binding protein ( L-FABP) were measured with enzyme-linked immunosorbent assay (ELISA), and serum creatinine, urine creatinine, Liver function, hemoglobin, glycated he-moglobin (HbA1c), albumin (Alb), and 24h urinary protein were measured by respective biochemical or immunological methods . Results With the progression of diabetic nephropathy , the level of urinary L-FABP was gradually increased ( P <0.01 ) , subgroup analysis showed that the level of urine L-FABP of normal albuminuria group was significantly higher than that of healthy group ( P <0.05 ) .The level of urine L-FABP of microalbuminuria group was significantly higher than that of normal albuminuria group ( P <0.01 ) .The level of urine L-FABP of clinical albuminuria group was significantly higher than that of microalbuminuria group ( P <0.01 ) .The level of urine L-FABP of renal failure group was significantly higher than that of clinical albuminuria group ( P <0.01 ) . The levels of urinary L-FABP was negatively correlated with estimated glomerular filtration rate ( eGFR) ( r =-0.812 , P <0.01 ) , was positively correlated with Scr ( r =0.901, P <0.01), and was no correlation with HbA1c ( P >0.05).Conclusions The uri-nary L-FABP level can predict the occurrence of early diabetic nephropathy , and also monitor the progression of diabetic nephropathy .